Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756700 | 0.84 | MMP1 (0.36) | MMP1MMP2MMP3MMP8 | |
| SCHEMBL6263428 | 0.79 | — | — | |
| SCHEMBL3258637 | 0.78 | LMNA (0.34) | MMP1MMP2MMP3MMP8 | |
| SCHEMBL18393481 | 0.78 | ALDH1A1 (0.33) | — | |
| SCHEMBL6264155 | 0.77 | ALDH1A1 (0.35) | — | |
| SCHEMBL5604146 | 0.77 | BTN3A1 (0.32) | — | |
| SCHEMBL6753441 | 0.68 | — | — | |
| SCHEMBL18825551 | 0.68 | LMNA (0.52) | MMP1MMP2MMP3MMP8 | |
| SCHEMBL27656990 | 0.66 | ALDH1A1 (0.36) | — | |
| SCHEMBL24753932 | 0.66 | LMNA (0.31) | MMP1MMP2MMP3MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6710149-B2 | USE OF ACRYLOPHOSPHONIC ACID AS A COMPONENT OF AN ADHESIVE, OF A POLYMER, OF A COMPOSITE, OF A CEMENT, OF A MOLDED ARTICLE AND IN PARTICULAR OF A DENTAL MATERIAL | IVOCLAR VIVADENT AG (LI) | 2004-03-23 | — | — | US | disclosed |
| EP-1148060-B1 | Hydrolysis-stable and polymerisable acrylphosphonic acids | IVOCLAR VIVADENT AG (LI) | 2003-09-10 | — | — | EP | disclosed |
| US-20020016384-A1 | Hydrolysis-stable and polymerizable acrylophosphonic acid | IVOCLAR VIVADENT AG. | 2002-02-07 | — | — | US | disclosed |
| EP-1148060-A1 | Hydrolysis-stable and polymerisable acrylphosphonic acids | Ivoclar Vivadent AG (LI) | 2001-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016384-A1 | Hydrolysis-stable and polymerizable acrylophosphonic acid | PHOSPHO1, PPA1, ABHD16A | MMP1 183/4885MMP2 641/4885MMP3 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.